ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE.
Camacho, Pauline M; Mazhari, Alaleh M; Wilczynski, Cory; Kadanoff, Ruth; Mumm, Steven; Whyte, Michael P.
; 22(8): 941-50, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27042741
FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
[Parathyroid hormone for disorders of calcium metabolism and metabolic bone diseases other than osteoporosis].
Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
Characteristics of Latinas in Puerto Rico and the US mainland receiving teriparatide in the DANCE observational study.
Optimización perioperatoria del paciente anciano con fractura osteoporótica de cadera.
Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.
Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
The theory of planned behaviour explains intentions to use antiresorptive medication after a fragility fracture.
Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.